Wednesday, March 6, 2013

Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Gui

Editors' Note: In response to "Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease," Dr. Suchowersky comments on the need for caution in prescribing tetrabenazine with other medications metabolized by cytochrome P450. Authors Armstrong and Miyasaki encourage clinicians to consult prescribing details before starting any medications. In reference to "Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis," Dr. Caplan points out that most recurrent strokes in patients with cervical dissections occur within 7 days, while the mean time of treatment after symptom onset in this study was 10.8 days. The authors respond that they are looking at the acute phase after cervical dissection in their ongoing randomized arm.








Júlio Leonardo B. Pereira
Phone: (+1) 424-2301706
Linkedin:http://www.linkedin.com/in/juliommais 
Site: www.neurocirurgiabr.com

No comments:

Post a Comment